跳至主要内容
临床试验/NCT01105494
NCT01105494已完成不适用

Prospective Study Evaluating the Quality of Life in Dialysis Patients With End Stage Renal Disease

Hoffmann-La Roche0 个研究点目标入组 6,000 人开始时间: 2008年12月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
6,000
主要终点
Quality of life assessment: Kidney Disease Quality of Life Questionnaire

研究概览

简要总结

This multicenter, prospective, observational study will evaluate the quality of life and the factors that influence the quality of life of epoetin beta [Neorecormon] in patients with renal chronic anemia, who are on dialysis. For each eligible patient data will be collected for 6 months. Target sample size is 5000-7000 patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients >/=18 years of age
  • Dialysis patients with chronic renal anemia
  • Written informed consent

排除标准

  • Red blood cell transfusion in the previous 2 months
  • Severe neuropsychological disorder
  • Diabetic patients with serious complications
  • This trial is being conducted in Morocco.

结局指标

主要结局

Quality of life assessment: Kidney Disease Quality of Life Questionnaire

时间窗: Throughout study: 6 months

次要结局

  • Evaluation of factors (demographic and social characteristics, dialysis method) influencing the quality of life(Throughout study: 6 months)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

An Observational Study of Epoetin Beta [Neorecormon]... | 临床试验